SCHEMBL5750217

SCHEMBL5750217

CC(C)c1cc(-c2cccc3cc[nH]c23)nc(N)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 1/20 0.51
▸ HTR2B P41595 1/20 0.51
▸ GPR65 Q8IYL9 1/20 0.51
▸ REN P00797 2/20 0.49
▸ PDPK1 O15530 2/20 0.46
▸ AURKA O14965 1/20 0.46
▸ TGFBR1 P36897 1/20 0.46
▸ AURKB Q96GD4 1/20 0.46
▸ CDK1 P06493 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ ADORA2A P29274 1/20 0.40
▸ PTPN11 Q06124 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ NR3C1 P04150 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ NR3C2 P08235 1/20 0.35
▸ AR P10275 1/20 0.35
▸ NUDT1 P36639 2/20 0.35
▸ BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746715 0.81 HTR1B (0.55) HTR1BHTR2BGPR65PDPK1AURKA
Hydrochloric Acid SCHEMBL5748450 0.80 HTR1B (0.54) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL5747652 0.78 HTR1B (0.70) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL5749142 0.73 HTR1B (0.84) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL7072365 0.70 HTR1B (0.74) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL5748001 0.69 HTR1B (0.54) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL31492457 0.69 AHR (0.60) RENPDPK1AHRNR3C1PGR
SCHEMBL5749889 0.69 HTR1B (0.72) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL29385708 0.68 HTR1B (1.00) HTR1BHTR2BGPR65PDPK1AURKA
SCHEMBL29391421 0.68 HTR1B (1.00) HTR1BHTR2BGPR65PDPK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 — — EP claimed
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 — — EP disclosed
EP-1321169-A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament Biofrontera Pharmaceuticals AG (DE) 2003-06-25 — — EP disclosed
CN-1109675-C Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2003-05-28 — — CN disclosed
US-5958934-A 5-HT 2B ANTAGONIST SYNTEX (U.S.A.) INC. (US) 1999-09-28 — — US disclosed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 — — US disclosed
CN-1223641-A Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 1999-07-21 — — CN disclosed
EP-0901474-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-17 — — EP disclosed
US-5863924-A Aryl pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1999-01-26 — — US disclosed
WO-1997044326-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-27 — — WO disclosed
Send feedback